Early value dossiers for medical technologies
The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders
Recent news and posts
Ongoing HTAs by IACS in Spain in March 2024
In March 2024, the Health Sciences Institute in Aragon (IACS) is working on several HTAs, including evaluations in diagnostic imaging, IVD, as well as clinical guidelines in endocrine, orthopedics, nephrology and urology, and some other fields. Some examples can be found below:
- Contrast-enhanced mammography in the diagnostic process of breast cancer;
- Techniques for quantification of Direct Action Oral Anticoagulants in plasma;
- Clinical practice guidelines for type 2 diabetes, chronic non-cancer pain, chronic kidney disease, mental disorder as well as prostate cancer.
The full details in Spanish can be found here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.